HK1011987A1 - Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines - Google Patents
Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicinesInfo
- Publication number
- HK1011987A1 HK1011987A1 HK98113239A HK98113239A HK1011987A1 HK 1011987 A1 HK1011987 A1 HK 1011987A1 HK 98113239 A HK98113239 A HK 98113239A HK 98113239 A HK98113239 A HK 98113239A HK 1011987 A1 HK1011987 A1 HK 1011987A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carboxamides
- medicines
- sulfonamidocarbonylpyridine
- sulphonamidocarbonyl
- sulphonamido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4209424 | 1992-03-24 | ||
| DE4238506 | 1992-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1011987A1 true HK1011987A1 (en) | 1999-07-23 |
Family
ID=25913130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98113239A HK1011987A1 (en) | 1992-03-24 | 1998-12-11 | Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5607954A (no) |
| EP (1) | EP0562512B1 (no) |
| JP (1) | JPH0649030A (no) |
| KR (1) | KR930019630A (no) |
| CN (1) | CN1076691A (no) |
| AT (1) | ATE199250T1 (no) |
| AU (1) | AU657608B2 (no) |
| CA (1) | CA2092276A1 (no) |
| CZ (1) | CZ46393A3 (no) |
| DE (1) | DE59310146D1 (no) |
| DK (1) | DK0562512T3 (no) |
| ES (1) | ES2154266T3 (no) |
| FI (1) | FI102895B1 (no) |
| GR (1) | GR3035479T3 (no) |
| HK (1) | HK1011987A1 (no) |
| HU (2) | HU219224B (no) |
| MY (1) | MY109143A (no) |
| NO (1) | NO179867C (no) |
| NZ (1) | NZ247201A (no) |
| PL (1) | PL173677B1 (no) |
| PT (1) | PT562512E (no) |
| RU (1) | RU2129545C1 (no) |
| SK (1) | SK280884B6 (no) |
| TW (1) | TW352384B (no) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650960B1 (de) * | 1993-11-02 | 1997-03-05 | Hoechst Aktiengesellschaft | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
| ATE149486T1 (de) * | 1993-11-02 | 1997-03-15 | Hoechst Ag | Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel |
| NZ270267A (en) * | 1993-12-30 | 1997-03-24 | Hoechst Ag | 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions |
| DE4410480A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE4410423A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE4410454A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE4410453A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
| IL135495A (en) * | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
| DE19742951A1 (de) | 1997-09-29 | 1999-04-15 | Hoechst Schering Agrevo Gmbh | Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung |
| DE19746287A1 (de) * | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| AR015733A1 (es) * | 1998-03-25 | 2001-05-16 | Otsuka Pharma Co Ltd | DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO. |
| US6583318B2 (en) | 2001-05-17 | 2003-06-24 | Advanced Syntech, Llc | Method for synthesis of α-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives |
| EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
| ES2414706T3 (es) | 2001-12-06 | 2013-07-22 | Fibrogen, Inc. | Métodos para aumentar la eritropoyetina endógena |
| US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8614204B2 (en) * | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| WO2006138511A2 (en) | 2005-06-15 | 2006-12-28 | Fibrogen, Inc. | Use of hif 1alfa modulators for treatment of cancer |
| KR100934674B1 (ko) * | 2006-03-30 | 2009-12-31 | 엘지전자 주식회사 | 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치 |
| EP3026044B8 (en) | 2006-06-26 | 2018-12-19 | Akebia Therapeutics, Inc. | Prolyl hydroxylase inhibitors and methods of use |
| WO2008147797A2 (en) * | 2007-05-25 | 2008-12-04 | Vertex Pharmaceuticals Incorporated | Ion channel modulators and methods of use |
| WO2009002533A1 (en) * | 2007-06-27 | 2008-12-31 | The Brigham And Women's Hospital, Inc. | Inflammatory bowel disease therapies |
| NO2686520T3 (no) | 2011-06-06 | 2018-03-17 | ||
| RU2627701C2 (ru) | 2012-02-22 | 2017-08-10 | Сэнфорд-Бёрнхэм Медикал Рисёрч Инститьют | Сульфонамидные соединения и их применение в качестве ингибиторов tnap |
| TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
| CN114404414A (zh) | 2013-06-13 | 2022-04-29 | 阿克比治疗有限公司 | 用于治疗贫血症的组合物和方法 |
| TWI665190B (zh) | 2013-11-15 | 2019-07-11 | 阿克比治療有限公司 | ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途 |
| US10150734B2 (en) | 2015-01-23 | 2018-12-11 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| CN106146395B (zh) * | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
| BR112017021097B1 (pt) | 2015-04-01 | 2024-01-02 | Akebia Therapeutics, Inc | Formulação de dosagem oral e seu uso |
| TW202406895A (zh) | 2018-05-09 | 2024-02-16 | 美商阿克比治療有限公司 | 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法 |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
| CN111972405A (zh) * | 2020-07-27 | 2020-11-24 | 南京太化化工有限公司 | 一种悬浮剂用助剂及异恶唑草酮悬浮剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| US5153208A (en) * | 1987-02-10 | 1992-10-06 | Hoechst Aktiengesellschaft | Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal compositions and methods of use |
| DE3703962A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE3928144A1 (de) * | 1989-08-25 | 1991-02-28 | Hoechst Ag | Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
-
1993
- 1993-03-09 TW TW082101698A patent/TW352384B/zh active
- 1993-03-19 NZ NZ247201A patent/NZ247201A/xx unknown
- 1993-03-22 CZ CZ93463A patent/CZ46393A3/cs unknown
- 1993-03-22 ES ES93104658T patent/ES2154266T3/es not_active Expired - Lifetime
- 1993-03-22 DK DK93104658T patent/DK0562512T3/da active
- 1993-03-22 SK SK223-93A patent/SK280884B6/sk unknown
- 1993-03-22 AT AT93104658T patent/ATE199250T1/de not_active IP Right Cessation
- 1993-03-22 MY MYPI93000506A patent/MY109143A/en unknown
- 1993-03-22 PT PT93104658T patent/PT562512E/pt unknown
- 1993-03-22 DE DE59310146T patent/DE59310146D1/de not_active Expired - Fee Related
- 1993-03-22 EP EP93104658A patent/EP0562512B1/de not_active Expired - Lifetime
- 1993-03-22 FI FI931250A patent/FI102895B1/fi active
- 1993-03-23 RU RU93004764A patent/RU2129545C1/ru active
- 1993-03-23 NO NO931056A patent/NO179867C/no not_active IP Right Cessation
- 1993-03-23 AU AU35369/93A patent/AU657608B2/en not_active Ceased
- 1993-03-23 PL PL93298195A patent/PL173677B1/pl unknown
- 1993-03-23 JP JP5063723A patent/JPH0649030A/ja active Pending
- 1993-03-23 CA CA002092276A patent/CA2092276A1/en not_active Abandoned
- 1993-03-23 CN CN93103349A patent/CN1076691A/zh active Pending
- 1993-03-24 HU HU9300850A patent/HU219224B/hu not_active IP Right Cessation
- 1993-03-24 KR KR1019930004589A patent/KR930019630A/ko not_active Application Discontinuation
-
1994
- 1994-12-13 US US08/355,419 patent/US5607954A/en not_active Expired - Fee Related
-
1995
- 1995-01-17 HU HU95P/P00068P patent/HU210714A9/hu unknown
-
1998
- 1998-12-11 HK HK98113239A patent/HK1011987A1/xx not_active IP Right Cessation
-
2001
- 2001-02-28 GR GR20010400321T patent/GR3035479T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1011987A1 (en) | Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines | |
| MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
| AU584124B2 (en) | Diarylacetylenes, their preparation and their use | |
| TW287160B (no) | ||
| SG43888A1 (en) | Novel sulfonylamino pyrimidines | |
| TW207533B (no) | ||
| IL111239A0 (en) | Substituted 1-naphthyl-3-pyrazolecarboxamides, their preparation and pharmaceutical compositions containing them | |
| CA2192480A1 (en) | Benzopyrans and their use as therapeutic agents | |
| ITMI913465A0 (it) | Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano | |
| ZA855224B (en) | Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use | |
| EP0292806A3 (en) | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | |
| PL312966A1 (en) | Derivatives of thiocarbamoil | |
| Martin | The aftermath of SIDS: Questioning the research | |
| Shorter | Spirit of Africa: The Healing Ministry of Archbishop Milingo of Zambia | |
| IL107142A0 (en) | Tetrahydroindazolone pharmaceutical compositions | |
| AU1845992A (en) | Use of 9, 12, 15-octadecatriene-6-ynoic acid | |
| ITRM930635A0 (it) | Composizione per biscotti aventi proprieta' antiacide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20050322 |